Diabetes Expert to Speak on Cellular Mechanisms of Insulin Resistance

Gerald I. Shulman

/kidneynews/7_10_11/30/graphic/30f1.jpg

A leading diabetes researcher will speak on “Cellular Mechanisms of Insulin Resistance: Implications for Obesity, Diabetes, and Metabolic Syndrome” at a state-of-the-art lecture on Saturday, Nov. 7.

Gerald I. Shulman, MD, PhD, is the George R. Cowgill Professor of Physiological Chemistry, Medicine, and Cellular and Molecular Physiology at Yale University, associate director of the Yale Diabetes Endocrine Research Center, and associate director of the Yale Medical Scientist Program. He is also an investigator of the Howard Hughes Medical Institute.

Dr. Shulman is an internationally recognized diabetes researcher and a leading authority on the cellular mechanisms of insulin resistance, the role of the liver and muscle in the pathogenesis of type 2 diabetes, and the benefits of exercise in the management of diabetes. Dr. Shulman pioneered the use of magnetic resonance spectroscopy to noninvasively examine intracellular glucose and fat metabolism in humans that has led to several paradigm shifts in our understanding of type 2 diabetes.

Dr. Shulman has received numerous awards, including the Outstanding Scientific Achievement Award and the Distinguished Clinical Scientist Award from the American Diabetes Association, the Diabetes Care Research Award from Boehringer-Mannheim/Juvenile Diabetes Foundation, and the Stanley Korsmeyer Award from the American Society for Clinical Investigation. He is a fellow of the American Association for the Advancement of Science and has been elected to the American Society for Clinical Investigation, Association of American Physicians, Institute of Medicine, and National Academy of Sciences.

Dr. Shulman completed his undergraduate studies in biophysics at the University of Michigan and received his MD and PhD degrees from Wayne State University. Following an internship and residency at Duke University Medical Center, he did an endocrinology fellowship at the Massachusetts General Hospital/Harvard Medical School and additional postdoctoral work in molecular biophysics and biochemistry at Yale. He joined the faculty at Harvard Medical School before being recruited back to Yale.